HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garuti, R. Articles by Calandra, S. Search for Related Content PubMed PubMed Citation Articles by Garuti, R. Articles by Calandra, S. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 37, 1459-1467, Copyright © 1996 by Lipid Research, Inc.

ARTICLES

Cerebrotendinous xanthomatosis caused by two new mutations of the sterol-27-hydroxylase gene that disrupt mRNA splicing

R Garuti, N Lelli, M Barozzini, R Tiozzo, MT Dotti, A Federico, AM Ottomano, A Croce, S Bertolini and S Calandra
Dipartimento di Scienze Biomediche, Universita di Modena, Italy.

Cerebrotendinous xanthomatosis (CTX) is an inherited sterol storage disease associated with the accumulation of cholestanol and cholesterol in various tissues. CTX is caused by a deficiency of sterol-27- hydroxylase, a mitochondrial enzyme that oxidizes the side chain of cholesterol in the pathway leading to the formation of bile acids. In the present study we report two mutations of sterol-27-hydroxylase gene (CYP27 gene) found in Italian CTX patients. Proband T.C. is homozygous for a G-->A transition at the first nucleotide of intron 7. This mutation causes the formation of minute amounts of an abnormal mRNA, in which exon 6 joins directly to exon 8 with the skipping of exon 7. The exon 6-exon 8 junction results in a frame shift, downstream from the codon for Arg362, which generates a string of 28 novel amino acids preceding a premature termination codon. Proband C.U. is homozygous for a G-->C transversion at the last nucleotide of exon 3. This mutation, which changes the consensus sequence of the 5' donor splice site, is associated with barely detectable levels of sterol-27-hydroxylase mRNA, of normal size, in proband fibroblasts. As both mutations change the sites for two restriction enzymes, rapid methods were devised for the identification of the healthy carriers among the probands' family members and for the screening of these mutations in other CTX patients.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. E. Prosser, Y. Guo, Z. Jia, and G. Jones Structural Motif-Based Homology Modeling of CYP27A1 and Site-Directed Mutational Analyses Affecting Vitamin D Hydroxylation Biophys. J., May 15, 2006; 90(10): 3389 - 3409. [Abstract] [Full Text] [PDF]

				K Ohno, A Tsujino, X-M Shen, M Milone, and A G Engel Spectrum of splicing errors caused by CHRNE mutations affecting introns and intron/exon boundaries J. Med. Genet., August 1, 2005; 42(8): e53 - e53. [Abstract] [Full Text] [PDF]

				A. Szanto, S. Benko, I. Szatmari, B. L. Balint, I. Furtos, R. Ruhl, S. Molnar, L. Csiba, R. Garuti, S. Calandra, et al. Transcriptional Regulation of Human CYP27 Integrates Retinoid, Peroxisome Proliferator-Activated Receptor, and Liver X Receptor Signaling in Macrophages Mol. Cell. Biol., September 15, 2004; 24(18): 8154 - 8166. [Abstract] [Full Text] [PDF]

				M.-H. Lee, S. Hazard, J. D. Carpten, S. Yi, J. Cohen, G. T. Gerhardt, G. Salen, and S. B. Patel Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees J. Lipid Res., February 1, 2001; 42(2): 159 - 169. [Abstract] [Full Text]

				G. M. Hobson, A. P. Davis, N. C. Stowell, E. H. Kolodny, E. A. Sistermans, I. F. M. de Coo, V. L. Funanage, and H. G. Marks Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease Neurology, October 24, 2000; 55(8): 1089 - 1096. [Abstract] [Full Text] [PDF]

				A. Verrips, L. H. Hoefsloot, G. C. H. Steenbergen, J. P. Theelen, R. A. Wevers, F. J. M. Gabreels, B. G. M. van Engelen, and L. P. W. J. van den Heuvel Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis Brain, May 1, 2000; 123(5): 908 - 919. [Abstract] [Full Text] [PDF]

				K Shiga, R Fukuyama, S Kimura, K Nakajima, and S Fushiki Mutation of the sterol 27-hydroxylase gene (CYP27) results in truncation of mRNA expressed in leucocytes in a Japanese family with cerebrotendinous xanthomatosis J. Neurol. Neurosurg. Psychiatry, November 1, 1999; 67(5): 675 - 677. [Abstract] [Full Text]

				N. Wakamatsu, M. Hayashi, H. Kawai, H. Kondo, Y. Gotoda, Y. Nishida, R. Kondo, S. Tsuji, and T. Matsumoto Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 195 - 198. [Abstract] [Full Text] [PDF]

				A. Verrips, G. J. Lycklama a Nijeholt, F. Barkhof, B. G. M. Van Engelen, P. Wesseling, J. A. F. M. Luyten, R. A. Wevers, J. Stam, J. H. J. Wokke, L. P. W. J. van den Heuvel, et al. Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis Brain, August 1, 1999; 122(8): 1589 - 1595. [Abstract] [Full Text] [PDF]

				W. Chen, S. Kubota, and Y. Seyama Alternative pre-mRNA splicing of the sterol 27-hydroxylase gene (CYP 27) caused by a G to A mutation at the last nucleotide of exon 6 in a patient with cerebrotendinous xanthomatosis (CTX) J. Lipid Res., March 1, 1998; 39(3): 509 - 517. [Abstract] [Full Text]